Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law FDA mulls compounding for peptides previously flagged over safety risks BioSpace RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Discover the shift in how certain peptides can now be legally prescribed and compounded by pharmacies. This change, influenced by Secretary Robert Kennedy's actions within the Department of Health and Human Services, What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B